investig
role
two
polymorph
site
bind
activ
formyl
peptid
receptor
fpr
viral
formyl
peptid
wedwvgwi
peptid
antivir
activ
deriv
membran
proxim
region
felin
immunodefici
viru
bind
high
affin
fpr
three
tryptophan
peptid
essenti
fpr
bind
essenti
antivir
activ
giannecchini
et
al
j
virol
formylnlewedwvgwi
behav
weak
partial
agonist
fpr
stronger
partial
agonist
fpr
fpr
formylnlenlewedwvgwi
behav
full
agonist
toward
three
fpr
exhibit
much
higher
ec
fpr
nm
fpr
nm
nm
formylmykwpwyvwl
preferenti
activ
fpr
fold
compar
fpr
formylmfedavawf
peptid
deriv
protein
mycobacterium
avium
subsp
paratuberculosi
formylmftfepfptn
peptid
deriv
nterminu
chemotaxi
inhibitori
protein
staphylococcu
aureu
ad
ntermin
methionin
exhibit
greatest
select
fpr
fold
lower
ec
observ
fpr
thu
individu
polymorph
may
display
reduc
abil
detect
certain
formyl
peptid
neutrophil
play
essenti
role
innat
immun
addit
activ
phagocytosi
secret
superoxid
hydrolyt
enzym
neutrophil
must
abl
chemotax
migrat
toward
sourc
chemoattract
formyl
peptid
receptor
fpr
chemoattract
g
proteincoupl
receptor
found
surfac
phagocyt
thought
play
import
role
allow
phagocyt
cell
recogn
presenc
bacteria
damag
cell
sinc
eubacteria
mitochondria
chloroplast
initi
protein
synthesi
formylmethionin
fpr
express
cell
also
exhibit
chemotaxi
toward
peptid
deriv
envelop
protein
peptid
deriv
herp
simplex
viru
type
elicit
chemotaxi
superoxid
product
neutrophil
process
appear
involv
fpr
addit
recent
observ
peptid
proxim
membran
region
fusion
protein
human
immunodefici
virus
sever
acut
respiratori
syndrom
coronaviru
coronavirus
hku
ebola
viru
potent
inhibitor
fpr
thu
fpr
appear
respond
presenc
viral
deriv
peptid
addit
bacteri
deriv
one
review
ligand
affect
fpr
see
two
protein
secret
aureu
inhibitor
fpr
chemotaxi
inhibitori
factor
aureu
chip
inhibit
fpr
receptor
homologu
chip
inhibitori
protein
flipr
inhibit
lesser
extent
fpr
nterminu
chip
essenti
bind
fpr
sinc
remov
ntermin
phenylalanin
reduc
affin
fpr
fold
peptid
deriv
nterminu
also
inhibitor
fpr
fold
lower
affin
chip
polymorph
fpr
common
sahagunruiz
et
al
extens
haplotyp
investig
fpr
report
find
least
haplotyp
fpr
polymorph
found
close
relat
receptor
present
explan
wide
sequenc
divers
fpr
numer
studi
indic
patient
aggress
periodont
exhibit
fold
reduct
chemotaxi
toward
fmlf
indic
reduc
abil
exhibit
chemotaxi
toward
formyl
peptid
may
associ
diseas
sever
studi
attempt
correl
fpr
polymorph
aggress
periodont
produc
conflict
result
lentivirus
associ
immunolog
impair
respect
host
human
immunodefici
felin
immunodefici
viral
infect
increas
likelihood
secondari
bacteri
infect
recent
kube
et
al
demonstr
felin
neutrophil
exhibit
mark
reduct
neutrophil
chemotaxi
toward
fmlf
follow
infect
fiv
ueda
et
al
note
envelop
abl
regul
express
fpr
sever
chemokin
receptor
low
nanomolar
concentr
downregul
fpr
chemokin
receptor
depend
upon
express
peptid
deriv
proxim
membran
region
siv
hrsv
human
parainfluenza
viru
type
measl
viru
coronaviru
shown
abl
block
viru
infect
eight
mer
peptid
deriv
proxim
membran
region
fiv
wedwvgwi
potent
low
nanomolar
inhibitor
fiv
infect
three
w
residu
essenti
activ
wherea
residu
unimport
activ
previous
observ
fpr
exhibit
enhanc
affin
bind
viral
peptid
reduc
affin
formyl
peptid
formylnleleuph
compar
fpr
fpr
assess
whether
three
w
residu
wedwvgwi
essenti
viral
inhibit
also
import
fpr
bind
also
undertook
extens
analysi
three
fpr
polymorph
use
varieti
formyl
peptid
vari
sequenc
order
identifi
formyl
peptid
might
behav
markedli
differ
toward
differ
polymorph
identifi
sever
formyl
peptid
exhibit
high
select
activ
compar
also
identifi
possibl
secondari
structur
chang
might
result
amino
acid
chang
secondari
structur
predict
correl
structur
chang
alter
bind
activ
fpr
cho
cell
express
prepar
describ
previous
peptid
obtain
genscript
pure
mass
spectral
data
provid
peptid
major
mass
peak
match
expect
mass
peptid
case
wedwvgwi
aedwvgvwi
wedavgwi
wedwvgai
n
acetyl
amid
cterminu
formyl
peptid
free
ctermini
ftfepfptn
free
nterminu
free
cterminu
formylnleleuph
obtain
sigma
use
without
purif
chip
purchas
cell
scienc
facscan
analysi
ligand
bind
fpr
express
cho
cell
cho
cell
gibco
chossfmii
ad
mm
kcl
nacl
mm
sodium
phosphat
ph
mm
mg
mm
ca
contain
fetal
bovin
serum
incub
c
min
vari
concentr
peptid
nm
formylnleleuphenletyrlysfitc
mean
fluoresc
cell
determin
mean
fluoresc
observ
non
express
cho
cell
nonspecif
bind
subtract
k
determin
nonlinear
least
squar
analysi
use
known
k
formylnleleuphenletyrlysfitc
fpr
variant
observ
ec
peptid
k
determin
equat
k
ec
ligandk
use
graphic
statist
program
graphpad
prizm
cho
cell
express
fpr
incub
gibco
chossfmii
c
hr
indic
time
figur
indict
concentr
peptid
dmso
case
cell
wash
ml
mm
phosphat
ph
mm
kcl
mm
nacl
c
cell
resuspend
mm
nacl
mm
kcl
mm
sodium
phosphat
ph
mm
mg
mm
ca
fetal
bovin
serum
nm
formylnleleuphenletyrlysfitc
incub
c
analyz
fascan
describ
receptor
recoveri
experi
cell
wash
ml
mm
phosphat
ph
mm
kcl
mm
nacl
c
incub
peptid
resuspend
gibco
chossfmii
c
indic
time
cell
wash
ml
mm
phosphat
ph
mm
kcl
mm
nacl
c
analyz
facscan
mean
fluoresc
cell
determin
mean
fluoresc
observ
non
express
cho
cell
nonspecif
bind
subtract
data
analyz
nonlinear
least
squar
analysi
ec
max
determin
partial
agonist
activ
max
downregul
fpr
compar
formylnleleuph
carri
day
experiment
result
express
standard
error
mean
signific
evalu
unpair
test
tail
use
comput
program
graphpad
prizm
fiv
peptid
nacetyl
camid
deriv
proxim
membran
region
assess
antivir
activ
therefor
nacetyl
camid
wedwvgwi
aedwvgvwi
wedavgwi
wedwvgai
synthes
evalu
abil
inhibit
formylnleleuphenletyrlysfitc
bind
fpr
figur
show
effect
peptid
bind
wedwvgwi
exhibit
appreci
inhibit
similar
giannecchini
et
al
observ
inhibit
viral
infect
fiv
inhibit
dose
depend
wedwvgwi
formylnlewedwvgwi
formylnlenlewedwvgwi
inhibit
formylnleleuphenletyrlysfitc
bind
determin
result
shown
tabl
thu
addit
formylnl
affect
affin
addit
formylnlenl
increas
affin
fpr
exhibit
fold
lower
affin
three
peptid
sinc
downregul
hallmark
receptor
activ
traffick
fpr
express
cho
cell
endocytot
vesicl
follow
treatment
fmlf
thoroughli
investig
chose
assay
highli
precis
way
evalu
ligand
activ
receptor
figur
show
time
cours
loss
surfac
receptor
three
fpr
variant
follow
treatment
formylnleleuph
exhibit
min
downregul
lesser
maximum
extent
figur
show
recoveri
surfac
receptor
treatment
formylnleleuph
hr
three
variant
exhibit
partial
recoveri
surfac
receptor
downregul
slightli
higher
recoveri
observ
determin
peptid
concentr
depend
downregul
surfac
express
receptor
assess
whether
peptid
exhibit
agonist
partial
agonist
antagonist
activ
observ
viral
peptid
wedwvgwi
caus
regul
concentr
wedwvgwi
inhibit
downregul
nm
formylnleleuph
three
fpr
data
shown
howev
formylnlewedwvgwi
behav
partial
agonist
figur
compar
formylnleleuph
figur
weak
partial
agonist
activ
observ
p
vs
either
greater
partial
agonist
activ
observ
also
exhibit
higher
ec
downregul
differ
signific
formylnlenlewedwvgwi
behav
full
agonist
three
fpr
figur
ec
nm
p
vs
either
fold
higher
either
nm
nm
despit
observ
k
differ
two
fold
observ
ec
fold
respect
k
fold
k
impli
formylnlenlewedwvgwi
time
effect
activ
larg
differ
ec
vs
k
mark
contrast
observ
formylnleleuph
figur
ec
similar
k
previous
report
ec
vs
k
ec
vs
k
ec
vs
k
thu
formylnlenlewedwvgwi
appear
behav
super
agonist
occup
receptor
abl
bring
intern
also
test
formylnlenlewedavgwi
figur
abil
caus
regul
receptor
behavior
essenti
ident
seen
formylnlenlewedwvgwi
contrast
wedavgwi
fold
weaker
wedwvgwi
bind
three
fpr
also
test
formylnlenlew
peptid
exhibit
littl
downregul
concentr
three
fpr
thu
vgwi
portion
peptid
formylnlenlewedwvgwi
appear
essenti
fpr
activ
test
formylmyvkwpwyvwl
previous
shown
essenti
ident
k
nm
abil
downregul
surfac
receptor
figur
exhibit
lowest
ec
nm
fold
observ
k
maximum
downregul
similar
seen
formylnleleuph
figur
fold
higher
ec
maximum
regul
similar
observ
formylnleleuph
ec
fold
greater
fold
greater
maximum
downregul
slightli
reduc
compar
seen
formylnleleuph
reduct
consist
reduc
stimul
bind
fpr
nm
formylmyvkwpwyvwl
compar
fpr
report
previous
carri
protein
blastp
search
http
wwwncbinlmnihgovblastblastcgi
pageprotein
programblastp
blastprogramsblastp
pagetypeblast
search
showdefaultson
sequenc
mmwedavgwi
nle
oxid
resist
analog
identifi
sequenc
similar
sequenc
formylnlenlewedavgwi
bacteria
use
search
organ
two
sequenc
reason
similar
mmwedavgwi
nterminu
identifi
ntermini
would
formyl
one
protein
map
mycobacterium
avium
subsp
paratuberculosi
protein
jnb
janibact
map
sequenc
investig
mfedavawf
ntermin
sequenc
formylmfedavawf
synthes
evalu
bind
downregul
formylmfedavawf
k
fold
higher
tabl
also
determin
ec
downregul
formylmfedavawf
behav
full
agonist
three
fpr
figur
peptid
activ
fold
weakli
either
ec
nm
nm
nm
respect
p
vs
either
formylmfedavawf
exhibit
similar
nterminu
chip
synthes
peptid
ftfepfptn
correspond
nterminu
chip
also
formylmftfepfptn
test
commerci
avail
chip
abil
inhibit
formylnleleuphenletyrlysfitc
bind
could
detect
inhibit
nm
fpr
variant
ftfepfptn
produc
littl
inhibit
formylnleleuphenletyrlysfitc
bind
also
inhibit
three
fpr
variant
formylmftfepfptn
effect
inhibit
three
variant
tabl
exhibit
significantli
differ
k
k
nm
nm
nm
respect
p
variant
vs
two
also
test
formylmftfepfptn
abil
downregul
figur
ec
nm
nm
nm
respect
p
variant
vs
two
maximum
downregul
similar
see
formylnleleuph
addit
formylmethionin
nterminu
ftfepfptn
enhanc
affin
fold
formylmftfepfptn
exhibit
affin
similar
seen
chip
k
nm
note
chip
origin
isol
secret
protein
aureu
mani
experi
done
use
chip
express
e
coli
properti
flipr
determin
e
coli
express
protein
e
coli
express
protein
would
expect
n
termin
formylmethionin
howev
author
note
differ
e
coli
express
chip
analyz
possibl
effect
secondari
structur
might
occur
respons
chang
posit
use
program
psipr
give
quantit
estim
secondari
structur
http
bioinfcsuclacukpsipr
result
shown
tabl
ii
sequenc
predict
rhodopsin
also
given
sinc
crystal
structur
known
tmh
v
rhodopsin
begin
first
residu
predict
non
zero
valu
helix
propens
underlin
residu
rhodopsin
sequenc
ident
fpr
exhibit
reduc
helix
propens
vs
summat
helix
propens
residu
ntermin
fpr
rhodopsin
underlin
tabl
ii
prisp
analysi
three
fpr
sequenc
suggest
tmh
v
longer
observ
rhodopsin
previous
suggest
base
kyte
doolittl
analysi
predict
begin
helix
v
vari
depend
upon
fpr
sequenc
interest
predict
effect
helix
propens
residu
ntermin
fpr
previous
shown
import
fpr
structur
sinc
fold
properli
retain
endoplasm
reticulum
sinc
prolin
secondari
amin
hydrogen
bond
destabil
helix
ntermin
prolin
rhodopsin
carbonyl
hydrogen
bond
carboxyl
occur
hydrogen
bond
residu
highli
conserv
gpcr
carbonyl
import
rhodopsin
activ
sinc
hydrogen
bond
disrupt
upon
rhodopsin
activ
previous
shown
analog
rhodopsin
import
fpr
activ
sinc
mutant
exhibit
poor
coupl
g
protein
poor
chemotaxi
toward
fmlf
fpr
hydrogen
bond
carbonyl
fpr
analog
rhodopsin
aromat
ring
exhibit
energet
favor
interact
carbonyl
oxygen
interact
carbonyl
disrupt
interact
ligand
bind
could
import
fpr
activ
fact
predict
exhibit
lower
helic
near
may
alter
abil
activ
respons
ligand
bind
previous
observ
polymorph
exhibit
slightli
reduc
fold
affin
formylnleleuph
fold
higher
affin
sever
viral
deriv
peptid
compar
either
observ
three
w
peptid
wedwvgwi
essenti
fpr
bind
essenti
antivir
activ
could
due
chang
structur
peptid
sinc
wedwvgai
shown
nmr
dmsowat
solut
adopt
differ
structur
wedwvgwi
nonetheless
correl
antivir
activ
abil
interact
fpr
intrigu
one
especi
sinc
fpr
abl
interact
proxim
membran
region
mani
virus
also
evalu
sever
formylnl
deriv
wedwvgwi
formylmyvkwpwyvwl
order
identifi
possibl
formyl
peptid
ligand
exhibit
markedli
differ
activ
toward
polymorph
also
identifi
similar
peptid
blastp
bacteri
sequenc
data
base
peptid
evalu
interact
similarli
fpr
formylmyvkwpwyvwl
formylmftfepfptn
activ
effect
activ
much
poorli
either
formyl
peptid
investig
exhibit
much
greater
differ
ec
observ
formylnleleuph
true
even
though
bound
formylnlenlewedwvgwi
formylmyvkwpwyvwl
similar
affin
observ
impli
w
posit
interfer
activ
process
alter
bind
constant
appreci
peptid
also
identifi
formyl
peptid
deriv
protein
mycobacterium
avium
subsp
paratuberculosi
formylmfedavawi
activ
fold
better
could
import
sinc
mycobacterium
avium
subsp
paratuberculosi
facult
intracellular
pathogen
macrophag
associ
john
diseas
cattl
may
associ
crohn
diseas
human
thu
replac
produc
profound
effect
activ
receptor
six
differ
formyl
peptid
compos
nine
residu
much
lesser
effect
tripeptid
formylnleleuph
formylmyvkwpwyvwl
formylnlenlewedwvgwi
formylnlenlewedavgwi
formylnlewedwvgwi
major
differ
abil
activ
receptor
differ
k
small
fold
less
formylmftfepfptn
formylmfedavawf
k
ec
markedli
increas
compar
either
rememb
k
reflect
bind
energi
use
promot
conform
chang
receptor
sinc
latter
potenti
energi
ec
downregul
therefor
may
better
represent
total
bind
energi
fact
addit
formylnl
wedwvgwi
littl
effect
affin
addit
formylmet
ftfepfptn
enhanc
affin
fold
impli
mark
differ
mode
bind
two
peptid
one
possibl
wedwvgwi
occupi
formylmet
formylnl
bind
pocket
ftfepfptn
fact
formylmftfepfptn
bind
similar
affin
chip
may
indic
intact
protein
residu
protein
abl
interact
formylmet
bind
site
substitut
activ
receptor
previous
propos
tmh
v
interact
cterminu
fmlf
essenti
bind
tripeptid
much
less
essenti
bind
larger
peptid
like
formylnleleuphenletyrlysfitc
also
shown
quench
fluoresc
formylnleleuphenletyrlysalexafluor
indic
must
resid
close
alexafluor
moieti
peptid
bound
fpr
find
consist
larger
effect
observ
longer
peptid
sinc
peptid
much
longer
three
residu
like
interact
near
r
addit
provid
formylmftfepfptn
good
model
chip
bind
might
indic
polymorph
would
resist
inhibit
chip
thu
polymorph
might
control
infect
aureu
better
polymorph
recent
studi
indic
high
percentag
normal
individu
express
antibodi
chip
polymorph
resist
effect
might
exhibit
select
advantag
sinc
retain
abil
interact
formyl
tri
peptid
